Skip to main content
. 2016 Apr 20;2016(4):CD012165. doi: 10.1002/14651858.CD012165

Morelli 2010.

Study characteristics
Patient sampling Primary objective: to determine whether relaxin and or its LGR7 receptor are expressed In human endometriotic tissues and whether their expression differs from that in endometrium of normal controls
Participants: women undergoing surgery for findings of an ovarian cyst on USS
Selection criteria: exclusion criteria: laparoscopic evidence and histologic confirmation of extra ovarian endometriosis at index surgery
Study design: observational single‐gate, prospective sample collection
Patient characteristics and setting Clinical presentation: ovarian cyst, not specified
Age: range 24‐37 years
Number enrolled: 40 women
Number available for analysis: 40 women (11 in proliferative and 29 in secretory phase of the cycle)
Setting: Department of Paediatrics, Obstetrics and Reproductive Medicine, University of Siena
Place of study: Siena, Italy
Period of study: October 2006 to May 2007
Language: English
Index tests Index test: Relaxin mRNA, LGR7 receptor mRNA
Description of positive case definition by index test as reported: LGR7 ‐ mRNA expression detected by RT‐PCR; Relaxin ‐ proportion of tissues expressing relaxin (detection by using the Rotor‐Gene 3000 PCR system (Corbett Research, CA) with using Platinum SYBR Green qPCR SuperMix (Invitrogen); normalised to β‐actin mRNA expression via 2‐ΔΔCt method; experiments described; thresholds not pre‐specified
Examiners: none stated; unclear if blinded to the results of reference standard
Interobserver variability: not provided
Target condition and reference standard(s) Target condition: ovarian endometriosis
Prevalence of target condition in the sample: n/N = 21/40 (52%): all stage III‐IV; controls 19
Reference standard: laparoscopy + histology
Description of positive case definition by reference test as reported: laparoscopic evidence and histologic confirmation of extra ovarian endometriosis; staging according to the rASRM classification
Examiners: none stated
Flow and timing Time interval between index test and reference standard: samples were collected at surgery (appears from the context)
Withdrawals: 8 patients with endometriosis were excluded as no tissue was available
Comparative  
Notes Conclusion: Significantly decreased expression of relaxin mRNA and LGR7 relaxin receptor mRNA in ectopic endometriotic tissues relative to their expression in eutopic endometrium and in endometrium from normal controls suggests that relaxin exerts a protective effect against endometriosis.
Comment:
For LGR7 relaxin receptor and relaxin mRNA there was no statistically significant difference between the groups; no data available for meta‐analysis (Appendix 7)
Methodological quality
Item Authors' judgement Risk of bias Applicability concerns
DOMAIN 1: Patient Selection
Was a consecutive or random sample of patients enrolled? No    
Did the study avoid inappropriate exclusions? Yes    
Was a 'two‐gate' design avoided? Yes    
    High High
DOMAIN 2: Index Test All tests
Were the index test results interpreted without knowledge of the results of the reference standard? No    
If a threshold was used, was it pre‐specified? No    
Was a menstrual cycle phase considered in interpreting the index test Yes    
    High Low
DOMAIN 3: Reference Standard
Is the reference standards likely to correctly classify the target condition? Yes    
Were the reference standard results interpreted without knowledge of the results of the index tests? Yes    
    Low Low
DOMAIN 4: Flow and Timing
Was there an appropriate interval between index test and reference standard? Unclear    
Did all patients receive the same reference standard? Yes    
Were all patients included in the analysis? No    
    High